In lung cancer cells, downregulation of PRMT5 or overexpression of PRMT1 promotes apoptosis induced by docetaxel and pemetrexed by modulating the degradation of the anti-apoptotic protein CFLARL (63). The gene discussed is PRMT1; the disease is lung carcinoma.